Invesco Ltd.

Position in ABSI — Absci Corp

CIK 914208 Atlanta, GA

Position in ABSI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$330,360

+$139,982 QoQ

Shares Held

110,120

+101.9% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 96.10879041046132.ToString("F0")% None 3.891209589538685.ToString("F0")%

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. ABSI ranks #190 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,724,478	$1,332,400,669
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,561,057	$1,143,614,384
3	ARGX	Argenx SE	594,697	$434,277,482
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,291,726	$427,393,371
5	INCY	Incyte Corp	3,870,764	$364,316,298
6	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
7	INSM	INSMED Inc	1,988,968	$325,236,040
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$330,360	110,120	+101.9%	Shares	Defined	2026-05-12
2025-12-31	$190,378	54,550	+14.3%	Shares	Defined	2026-02-19
2025-09-30	$145,080	47,724	+6.1%	Shares	Defined	2025-11-13
2025-06-30	$115,638	44,996	+6.5%	Shares	Defined	2025-08-13
2025-03-31	$106,069	42,259	-2.9%	Shares	Defined	2025-05-12
2024-12-31	$114,061	43,535	+15.1%	Shares	Defined	2025-02-13
2024-09-30	$144,456	37,816	-0.2%	Shares	Defined	2024-11-12
2024-06-30	$116,731	37,900	+129.5%	Shares	Defined	2024-08-13
2023-03-31	$28,902	16,516	-6.9%	Shares	Defined	2023-05-12
2022-12-31	$37,262	17,744	-0.9%	Shares	Defined	2023-02-13
2022-09-30	$56,017	17,897	-0.6%	Shares	Defined	2022-11-14
2022-06-30	$59,749	17,997	+57.0%	Shares	Defined	2022-08-15
2022-03-31	$96,607	11,460	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.